# HMI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hmi

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.hmibiotech.com
- Latest round: Angel (Aug 1, 2017)
- Investors on record: 2

## About

Founded in 2017 and based in Shenzhen, China, HMI operates as a medical company that focuses on the development and production of diagnostic reagents. It has branch offices in Shanghai and Shenzhen. The metabolomics research and development team and biological big data analysis team led by the founder Professor Jia Wei cooperated with the laboratory of Jeremy Nicholson, the founder of metabolomics, and other domestic and foreign biological laboratories. It cooperates with companies such as Waters and Nestle, tertiary hospitals such as Peking Union Medical College Hospital, Shanghai First People's Hospital, and Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, and world-class universities such as Peking University, Fudan University, and Shanghai Jiaotong University. In August 2025, HMI raised Series A++ funding from new investor Huiding Medical Investment.
HMI mainly engages in the research and development of in vitro diagnostic products as well as scientific research and medical testing services. Its vitro diagnostic products include Diabetes Screening Kits and Alzheimer's Disease Risk Screening Kits. The company also developed GCTOF spectrum peak integration software and LiveForest metabolomics-based machine learning system for chronic liver diseases. The company generates revenue by providing vitro diagnostic products as well as scientific research and medical testing services.

## Funding rounds

- Angel, Aug 1, 2017 — Virtus Inspire Ventures, Hyfinity Investments

## Investors

- Virtus Inspire Ventures (https://capitalatlas.ai/funds/virtus-inspire-ventures) — Angel
- Hyfinity Investments (https://capitalatlas.ai/funds/hyfinity-investments) — Angel